Cameron Kevin J 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jun 18, 2018
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Exercise/Conversion
Common Stock
2018-06-15$0.48/sh+10,000$4,800→ 178,333 total - Exercise/Conversion
Stock Options (right to buy)
2018-06-15−10,000→ 0 totalExercise: $0.48From: 2008-06-18Exp: 2018-06-18→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Includes 9,999 shares of restricted stock.
- [F2]The stock options vested according to the following schedule: one-half of the 10,000 options vested on June 18, 2008 and one-half vested on June 18, 2009.